查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451212

2024-2032 年按產品和服務類型、測試類型、疾病、最終用戶和地區分類的呼吸診斷市場報告

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球呼吸診斷市場規模達80億美元。展望未來， IMARC Group預計到2032年市場規模將達到147億美元，2024-2032年複合年成長率（CAGR）為6.8%。

呼吸診斷是指肺功能和相關過程的臨床評估。它包括多種機械、影像和分子診斷測試，用於檢測氣喘、慢性阻塞性肺病 (COPD)、肺癌、支氣管炎和肺纖維化。它使用的程序包括肺活量測定、血氧測定、經皮二氧化碳監測、鼻吸氣壓 (SNIP)、胸部 X 光檢查和電腦斷層掃描 (CT) 掃描。在某些情況下，還進行睡眠研究來診斷和評估睡眠呼吸中止症和夜間通氣不足的存在。

呼吸系統疾病的日益普及是推動市場成長的關鍵因素之一。吸菸和飲酒人數不斷增加，加上久坐的生活習慣和壓力過大，導致慢性阻塞性肺病和肺癌等其他嚴重呼吸道疾病的發生率上升。此外，呼吸診斷測試的各種技術創新，包括利用物聯網（IoT）和人工智慧（AI）來診斷慢性阻塞性肺病和門診管理，正在對市場成長產生積極影響。此外，各種私人醫院和醫療中心對呼吸診斷設備的需求增加，以及政府和非政府組織 (NGO) 為向所有人提供優質醫療設施而做出的努力，正在推動呼吸診斷市場的發展。其他促進市場成長的因素包括加強研發（R＆D）、不斷增加的老年人口、快速城市化和不斷增加的工業設施以及全球污染水平的不斷上升。

本報告回答的關鍵問題：

  • 迄今為止，全球呼吸診斷市場表現如何，未來幾年將如何表現？
  • 全球呼吸診斷產業的主要區域市場有哪些？
  • COVID-19 對全球呼吸診斷產業有何影響？
  • 基於產品和服務類型的市場區隔是什麼？
  • 根據測試類型，市場的細分是什麼？
  • 基於疾病的市場崩盤是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 全球呼吸診斷產業價值鏈的各個階段是什麼？
  • 全球呼吸診斷產業的關鍵促進因素和挑戰是什麼？
  • 全球呼吸診斷產業的結構如何？誰是關鍵參與者？
  • 全球呼吸診斷產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球呼吸診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：依產品及服務類型
  • 市場區隔：按測試類型
  • 市場區隔：依疾病分類
  • 市場區隔：按最終用戶
  • 市場區隔：按地區
  • 市場預測

第 6 章：市場區隔：依產品與服務類型

  • 儀器和服務
    • 市場走向
    • 市場預測
  • 測定和試劑
    • 市場走向
    • 市場預測
  • 服務和軟體
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按測試類型

  • 機械測試
    • 市場走向
    • 市場預測
  • 阻塞性睡眠呼吸中止症 (OSA) 診斷測試
    • 市場走向
    • 市場預測
  • 影像學檢查
    • 市場走向
    • 市場預測
  • 傳統診斷測試
    • 市場走向
    • 市場預測
  • 分子診斷測試
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依疾病分類

  • 結核
    • 市場走向
    • 市場預測
  • 氣喘
    • 市場走向
    • 市場預測
  • 慢性阻塞性肺病（COPD）
    • 市場走向
    • 市場預測
  • 肺癌
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 參考和臨床實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
Product Code: SR112024A1620

The global respiratory diagnostics market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory diagnostics market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product and service type, test type, disease and end-user.

Breakup by Product and Service Type:

Instruments and Services

Assays and Reagents

Services and Software

Breakup by Test Type:

Mechanical Tests

Obstructive Sleep Apnoea (OSA) Diagnostic Tests

Imaging Tests

Traditional Diagnostic Tests

Molecular Diagnostic Tests

Others

Breakup by Disease:

Tuberculosis

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Lung Cancer

Others

Breakup by End-User:

Hospitals

Clinics

Reference and Clinical Laboratories

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

  • How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global respiratory diagnostics industry?
  • What has been the impact of COVID-19 on the global respiratory diagnostics industry?
  • What is the breakup of the market based on the product and service type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global respiratory diagnostics industry?
  • What are the key driving factors and challenges in the global respiratory diagnostics industry?
  • What is the structure of the global respiratory diagnostics industry and who are the key players?
  • What is the degree of competition in the global respiratory diagnostics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2023
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 11: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million US$), 2024-2032
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players